<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="21336">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02829112</url>
  </required_header>
  <id_info>
    <org_study_id>6177</org_study_id>
    <nct_id>NCT02829112</nct_id>
  </id_info>
  <brief_title>Shulman Fasciitis Prevalence Study in Alsace</brief_title>
  <acronym>SHULMAN</acronym>
  <official_title>Shulman Fasciitis Prevalence Study in Alsace</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Strasbourg, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Strasbourg, France</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Shulman fasciitis or eosinophilic fasciitis (EF) is a rare inflammatory disease, usually
      benign but disabling, described by Shulman in 1974. The diagnosis is suggested by the
      clinic, confirmed by MRI and confirmed by histology, there really no published diagnostic
      criteria validated for this rare disease. The low number of cases reported in the literature
      reflects the difficulty of studying the epidemiology of this disease, to establish and
      evaluate therapeutic strategies and to assess prognosis. Work on this subject are few. To
      our knowledge, no study has previously used to estimate the incidence and prevalence of this
      disease. Therefore, the investigators want to determine the prevalence of FEs in Alsace in
      2016 by a study &quot;capture-recapture&quot; using several independent sources of identification of
      cases in order to have recent epidemiological data and learn more about this disease.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>July 2016</start_date>
  <completion_date type="Anticipated">July 2017</completion_date>
  <primary_completion_date type="Anticipated">July 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Schulmann fasciitis</measure>
    <time_frame>all living patients in Alsace from 1 January 2016 to december 2016</time_frame>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Shulman Fasciitis</condition>
  <eligibility>
    <study_pop>
      <textblock>
        All patients suffering from fasciitis Shulmande and living in Alsace at 1 January 2016
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients aged over 18 years

          -  Patients suffering from fasciitis Shulmande and living in Alsace at 1 January 2016

        Exclusion Criteria:

          -  refusal to participate in the study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Jean SIBILIA, MD, PhD</last_name>
    <phone>33 (0)3 88 12 79 54</phone>
    <email>jean.sibilia@chru-strasbourg.fr</email>
  </overall_contact>
  <verification_date>June 2016</verification_date>
  <lastchanged_date>July 7, 2016</lastchanged_date>
  <firstreceived_date>June 16, 2016</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Shulman</keyword>
  <keyword>fasciitis</keyword>
  <keyword>Shulman fasciitis</keyword>
  <keyword>eosinophilic fasciitis</keyword>
  <keyword>inflammatory disease</keyword>
  <keyword>prevalence</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Fasciitis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
